1. Home
  2. SSTK vs AGMB Comparison

SSTK vs AGMB Comparison

Compare SSTK & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$5.68

Market Cap

570.9M

Sector

Technology

ML Signal

HOLD

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$12.55

Market Cap

562.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSTK
AGMB
Founded
2003
2017
Country
United States
Belgium
Employees
N/A
62
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
570.9M
562.4M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SSTK
AGMB
Price
$5.68
$12.55
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$25.00
$32.00
AVG Volume (30 Days)
1.3M
89.8K
Earning Date
04-28-2026
04-23-2026
Dividend Yield
8.61%
N/A
EPS Growth
23.76
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.35
N/A
Revenue Next Year
N/A
$17.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$8.75
52 Week High
$29.50
$17.82

Technical Indicators

Market Signals
Indicator
SSTK
AGMB
Relative Strength Index (RSI) 19.98 51.94
Support Level N/A $9.54
Resistance Level $17.67 $14.19
Average True Range (ATR) 0.64 1.01
MACD -0.13 -0.09
Stochastic Oscillator 11.30 49.91

Price Performance

Historical Comparison
SSTK
AGMB

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: